- Home
- FVRR vs QURE Comparison
FVRR vs QURE Comparison
Compare FVRR & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVRR
- QURE
- Stock Information
- Founded
- FVRR 2010
- QURE 1998
- Country
- FVRR Israel
- QURE Netherlands
- Employees
- FVRR N/A
- QURE N/A
- Industry
- FVRR Business Services
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- FVRR Consumer Discretionary
- QURE Health Care
- Exchange
- FVRR Nasdaq
- QURE Nasdaq
- Market Cap
- FVRR 933.7M
- QURE 866.3M
- IPO Year
- FVRR 2019
- QURE 2007
- Fundamental
- Price
- FVRR $23.36
- QURE $65.06
- Analyst Decision
- FVRR Buy
- QURE Strong Buy
- Analyst Count
- FVRR 11
- QURE 12
- Target Price
- FVRR $32.91
- QURE $69.67
- AVG Volume (30 Days)
- FVRR 822.3K
- QURE 7.4M
- Earning Date
- FVRR 10-29-2025
- QURE 11-04-2025
- Dividend Yield
- FVRR N/A
- QURE N/A
- EPS Growth
- FVRR 70.84
- QURE N/A
- EPS
- FVRR 0.50
- QURE N/A
- Revenue
- FVRR $419,126,000.00
- QURE $14,337,000.00
- Revenue This Year
- FVRR $12.80
- QURE N/A
- Revenue Next Year
- FVRR $6.58
- QURE $287.72
- P/E Ratio
- FVRR $47.39
- QURE N/A
- Revenue Growth
- FVRR 12.60
- QURE N/A
- 52 Week Low
- FVRR $20.83
- QURE $5.23
- 52 Week High
- FVRR $36.11
- QURE $61.80
- Technical
- Relative Strength Index (RSI)
- FVRR 45.33
- QURE 83.71
- Support Level
- FVRR $23.25
- QURE $50.80
- Resistance Level
- FVRR $24.39
- QURE $57.57
- Average True Range (ATR)
- FVRR 0.82
- QURE 5.15
- MACD
- FVRR -0.15
- QURE 1.73
- Stochastic Oscillator
- FVRR 8.28
- QURE 99.71
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.